GZMB and neoplasm: Additionally, granzyme B+ cells were more abundant in tumors treated with EcN-IL-15/CR + L than in EcN-IL-15/CR or EcN/CR + L groups (Figure 5K), indicating enhanced lymphocyte cytotoxicity for tumor elimination.45